AMAlan J. Meehan

Alan J. Meehan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alan J. Meehan has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnosis provision by young people's mental health services: a population-based study in South London integrating epidemiological estimates

    by Stephanie J. Lewis, Alan J. Meehan, Mia Akiba, Louise Arseneault, Sarah Byford, Avshalom Caspi, Bruce R. Clark, Johnny Downs, Helen L. Fisher, Tamsin J. Ford, et al.

  • Open Access

    Debate: Is ACE screening doing more harm than good? Beyond the ACE score – towards more personalised approaches to risk prediction

    by Alan J. Meehan, Stephanie J. Lewis, Andrea Danese

    Adverse childhood experiences (ACEs) are strongly associated with later mental and physical health problems, prompting growing interest in ACE screening to identify vulnerable children and adults who may benefit from interventions to prevent or mitigate these outcomes. However, evidence supporting routine ACE screening in clinical practice remains limited. Although cumulative ACE scores demonstrate robust population‐level associations with health outcomes, their individual predictive accuracy is consistently poor, with substantial false‐positive and false‐negative classifications and potential for inequitable outcomes across demographic groups. Existing screening approaches also fail to capture important contextual differences among reported ACEs, as well as factors that may promote resilience. Furthermore, positive screening results are not currently linked to clearly established, evidence‐based clinical pathways, raising wider concerns around labelling stigma and missed needs. Therefore, widespread implementation of ACE screening in its current form cannot be recommended to prevent poor health. However, future approaches that move beyond cumulative adversity counts towards more nuanced, personalised and proportionate ACE measures, which also consider broader developmental, social and protective factors, have the potential to inform more personalised risk assessment following childhood adversity.


  • Revisiting the use of adverse childhood experience screening in healthcare settings

    by Andrea Danese, Kirsten Asmussen, Jelena MacLeod, Alan Meehan, Jessica Sears, Natalie Slopen, Patrick Smith, Angela Sweeney


  • Open Access

    Individualized prediction models in ADHD: a systematic review and meta-regression

    by Gonzalo Salazar de Pablo, Raquel Iniesta, Alessio Bellato, Arthur Caye, Maja Dobrosavljevic, Valeria Parlatini, Miguel Garcia-Argibay, Lin Li, Anna Cabras, Mian Haider Ali, et al.

    There have been increasing efforts to develop prediction models supporting personalised detection, prediction, or treatment of ADHD. We overviewed the current status of prediction science in ADHD by: (1) systematically reviewing and appraising available prediction models; (2) quantitatively assessing factors impacting the performance of published models. We did a PRISMA/CHARMS/TRIPOD-compliant systematic review (PROSPERO: CRD42023387502), searching, until 20/12/2023, studies reporting internally and/or externally validated diagnostic/prognostic/treatment-response prediction models in ADHD. Using meta-regressions, we explored the impact of factors affecting the area under the curve (AUC) of the models. We assessed the study risk of bias with the Prediction Model Risk of Bias Assessment Tool (PROBAST). From 7764 identified records, 100 prediction models were included (88% diagnostic, 5% prognostic, and 7% treatment-response). Of these, 96% and 7% were internally and externally validated, respectively. None was implemented in clinical practice. Only 8% of the models were deemed at low risk of bias; 67% were considered at high risk of bias. Clinical, neuroimaging, and cognitive predictors were used in 35%, 31%, and 27% of the studies, respectively. The performance of ADHD prediction models was increased in those models including, compared to those models not including, clinical predictors (β = 6.54, p = 0.007). Type of validation, age range, type of model, number of predictors, study quality, and other type of predictors did not alter the AUC. Several prediction models have been developed to support the diagnosis of ADHD. However, efforts to predict outcomes or treatment response have been limited, and none of the available models is ready for implementation into clinical practice. The use of clinical predictors, which may be combined with other type of predictors, seems to improve the performance of the models. A new generation of research should address these gaps by conducting high quality, replicable, and externally validated models, followed by implementation research.


  • Top Cited Papers
    Open Access

    Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges

    by Alan J. Meehan, Stephanie J. Lewis, Seena Fazel, Paolo Fusar-Poli, Ewout W. Steyerberg, Daniel Stahl, Andrea Danese

    Recent years have seen the rapid proliferation of clinical prediction models aiming to support risk stratification and individualized care within psychiatry. Despite growing interest, attempts to synthesize current evidence in the nascent field of precision psychiatry have remained scarce. This systematic review therefore sought to summarize progress towards clinical implementation of prediction modeling for psychiatric outcomes. We searched MEDLINE, PubMed, Embase, and PsychINFO databases from inception to September 30, 2020, for English-language articles that developed and/or validated multivariable models to predict (at an individual level) onset, course, or treatment response for non-organic psychiatric disorders (PROSPERO: CRD42020216530). Individual prediction models were evaluated based on three key criteria: (i) mitigation of bias and overfitting; (ii) generalizability, and (iii) clinical utility. The Prediction model Risk Of Bias ASsessment Tool (PROBAST) was used to formally appraise each study’s risk of bias. 228 studies detailing 308 prediction models were ultimately eligible for inclusion. 94.5% of developed prediction models were deemed to be at high risk of bias, largely due to inadequate or inappropriate analytic decisions. Insufficient internal validation efforts (within the development sample) were also observed, while only one-fifth of models underwent external validation in an independent sample. Finally, our search identified just one published model whose potential utility in clinical practice was formally assessed. Our findings illustrated significant growth in precision psychiatry with promising progress towards real-world application. Nevertheless, these efforts have been inhibited by a preponderance of bias and overfitting, while the generalizability and clinical utility of many published models has yet to be formally established. Through improved methodological rigor during initial development, robust evaluations of reproducibility via independent validation, and evidence-based implementation frameworks, future research has the potential to generate risk prediction tools capable of enhancing clinical decision-making in psychiatric care.


  • Top Cited Papers
    Open Access

    Poor Individual Risk Classification From Adverse Childhood Experiences Screening

    by Alan J. Meehan, Jessie R. Baldwin, Stephanie J. Lewis, Jelena G. MacLeod, Andrea Danese


  • Open Access

    Using a Loneliness Measure to Screen for Risk of Mental Health Problems: A Replication in Two Nationally Representative Cohorts

    by Timothy Matthews, Bridget T. Bryan, Andrea Danese, Alan J. Meehan, Richie Poulton, Louise Arseneault

    Background: Loneliness co-occurs alongside many mental health problems and is associated with poorer treatment outcomes. It could therefore be a phenomenon of interest to clinicians as an indicator of generalised risk for psychopathology. The present study tested whether a short measure of loneliness can accurately classify individuals who are at increased risk of common mental health problems. Methods: Data were drawn from two nationally representative cohorts: the age-18 wave of the UK-based Environmental Risk (E-Risk) Longitudinal Twin Study and the age-38 wave of the New Zealand-based Dunedin Multidisciplinary Health and Development Study. In both cohorts, loneliness was assessed using the three-item UCLA Loneliness Scale, plus two stand-alone items about feeling alone and feeling lonely. Outcome measures consisted of diagnoses of depression and anxiety and self-reports of self-harm/suicide attempts, assessed via a structured interview. Results: ROC curve analysis showed that the Loneliness Scale had fair accuracy in classifying individuals meeting criteria for all three outcomes, with a cut-off score of 5 (on a scale from 3 to 9) having the strongest empirical support. Both of the stand-alone items showed modest sensitivity and specificity but were more limited in their flexibility. The findings were replicated across the two cohorts, indicating that they are applicable both to younger and older adults. In addition, the accuracy of the loneliness scale in detecting mental health problems was comparable to a measure of poor sleep quality, a phenomenon which is often included in screening tools for depression and anxiety. Conclusions: These findings indicate that a loneliness measure could have utility in mental health screening contexts, as well as in research.


  • Open Access

    Developmental pathways from toddler difficult temperament to child generalized psychopathology and adult functioning

    by Tom C.-H. Wu, Alan J. Meehan, Jolien Rijlaarsdam, Barbara Maughan, Pasco Fearon, Edward D. Barker


  • Open Access

    Neonatal DNA methylation and childhood low prosocial behavior: An epigenome‐wide association meta‐analysis

    by Mannan Luo, Alan J. Meehan, Esther Walton, Stefan Röder, Gunda Herberth, Ana C. Zenclussen, Marta Cosín‐Tomás, Jordi Sunyer, Rosa H. Mulder, Andrea P. Cortes Hidalgo, et al.

    Low prosocial behavior in childhood has been consistently linked to later psychopathology, with evidence supporting the influence of both genetic and environmental factors on its development. Although neonatal DNA methylation (DNAm) has been found to prospectively associate with a range of psychological traits in childhood, its potential role in prosocial development has yet to be investigated. This study investigated prospective associations between cord blood DNAm at birth and low prosocial behavior within and across four longitudinal birth cohorts from the Pregnancy And Childhood Epigenetics (PACE) Consortium. We examined (a) developmental trajectories of “chronic‐low” versus “typical” prosocial behavior across childhood in a case–control design (N = 2,095), and (b) continuous “low prosocial” scores at comparable cross‐cohort time‐points (N = 2,121). Meta‐analyses were performed to examine differentially methylated positions and regions. At the cohort‐specific level, three CpGs were found to associate with chronic low prosocial behavior; however, none of these associations was replicated in another cohort. Meta‐analysis revealed no epigenome‐wide significant CpGs or regions. Overall, we found no evidence for associations between DNAm patterns at birth and low prosocial behavior across childhood. Findings highlight the importance of employing multi‐cohort approaches to replicate epigenetic associations and reduce the risk of false positive discoveries.